By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
It has been a mixed year for Aurinia Pharmaceuticals Inc. insiders: $25.1 million bought by two people and $546,000 sold by one, so more buying than selling overall.
TANG KEVIN (CEO) made the biggest buy, worth around $5.2 million. That includes C-suite money, which tends to get the most attention.
Zooming out by quarter: Last full quarter: net selling by insiders. Insiders bought in 4 of the last 7 full quarters. Big money check: 281 institutions held AUPH as of Q2 2026, and more funds bought than sold.
Are insiders buying or selling AUPH stock?
In the last 12 months Aurinia Pharmaceuticals Inc. insiders made open-market purchases worth about $25.1 million and sales worth about $546,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in AUPH?
The most recent open-market insider trade in AUPH was filed on 2026-09-11.
How many institutions own AUPH?
281 investment managers reported holding AUPH in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded AUPH?
No congressional trades in AUPH were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).